Adults with dyslipidemia and evidence of mild systemic inflammation ( high-sensitivity C-reactive protein -LSB- hs-CRP -RSB- between @ and @mg/L ) were randomly allocated to receive either @ mg of cis-palmitoleic acid ( n = @ ) or an identical capsule with placebo ( @mg of medium chain triglycerides , n = @ ) once per day for @days .